Cargando…
Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
BACKGROUND: T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease with the need for treatment optimization. Previously, high expression of Insulin-like growth factor binding protein 7 (IGFBP7), a member of the IGF system, was identified as negative prognostic factor in a...
Autores principales: | Bartram, Isabelle, Erben, Ulrike, Ortiz-Tanchez, Jutta, Blunert, Katja, Schlee, Cornelia, Neumann, Martin, Heesch, Sandra, Baldus, Claudia D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599323/ https://www.ncbi.nlm.nih.gov/pubmed/26450156 http://dx.doi.org/10.1186/s12885-015-1677-z |
Ejemplares similares
-
Mutational spectrum of adult T-ALL
por: Neumann, Martin, et al.
Publicado: (2014) -
Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
por: Fransecky, L., et al.
Publicado: (2016) -
An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse
por: Bartsch, Lorenz, et al.
Publicado: (2022) -
Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
por: Bartram, Isabelle, et al.
Publicado: (2014) -
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
por: Liebig, Sven, et al.
Publicado: (2023)